David Sedwick

675 total citations
7 papers, 514 citations indexed

About

David Sedwick is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, David Sedwick has authored 7 papers receiving a total of 514 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 2 papers in Oncology and 2 papers in Cell Biology. Recurrent topics in David Sedwick's work include RNA modifications and cancer (3 papers), Ubiquitin and proteasome pathways (2 papers) and Histone Deacetylase Inhibitors Research (2 papers). David Sedwick is often cited by papers focused on RNA modifications and cancer (3 papers), Ubiquitin and proteasome pathways (2 papers) and Histone Deacetylase Inhibitors Research (2 papers). David Sedwick collaborates with scholars based in United States, China and Sweden. David Sedwick's co-authors include Zhenghe Wang, Sanford D. Markowitz, Rob M. Ewing, Jing Song, Yiqing Zhao, Shuming Yang, Hung‐Ying Kao, Yong Wang, Zhanwen Du and Joseph Willis and has published in prestigious journals such as Cancer Cell, Oncogene and British Journal of Pharmacology.

In The Last Decade

David Sedwick

7 papers receiving 509 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Sedwick United States	6	446	137	63	61	48	7	514
Milena Vuica‐Ross United States	12	465 1.0×	130 0.9×	74 1.2×	44 0.7×	93 1.9×	20	679
Þorkell Guðjόnsson Denmark	7	558 1.3×	213 1.6×	83 1.3×	71 1.2×	36 0.8×	10	658
Roel H. Wilting Netherlands	4	443 1.0×	130 0.9×	86 1.4×	31 0.5×	41 0.9×	4	547
Serguei R. Romanov United States	4	359 0.8×	205 1.5×	72 1.1×	69 1.1×	42 0.9×	7	583
Senthilkumar Cinghu United States	12	706 1.6×	136 1.0×	156 2.5×	54 0.9×	52 1.1×	16	842
Brendon Ladd United States	11	489 1.1×	109 0.8×	106 1.7×	63 1.0×	29 0.6×	19	584
Arunasalam Navaraj United States	12	337 0.8×	219 1.6×	77 1.2×	47 0.8×	54 1.1×	16	466
Kristen Bisanz United States	6	287 0.6×	124 0.9×	58 0.9×	34 0.6×	37 0.8×	7	389
Colleen Crane Canada	4	212 0.5×	116 0.8×	97 1.5×	47 0.8×	44 0.9×	5	397
Chen‐Chun Pai United Kingdom	9	521 1.2×	114 0.8×	70 1.1×	33 0.5×	19 0.4×	16	587

Countries citing papers authored by David Sedwick

Since Specialization

Citations

This map shows the geographic impact of David Sedwick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Sedwick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Sedwick more than expected).

Fields of papers citing papers by David Sedwick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Sedwick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Sedwick. The network helps show where David Sedwick may publish in the future.

Co-authorship network of co-authors of David Sedwick

This figure shows the co-authorship network connecting the top 25 collaborators of David Sedwick. A scholar is included among the top collaborators of David Sedwick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Sedwick. David Sedwick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Nandadasa, Sumeda, Jason M. Szafron, Sae‐Il Murtada, et al.. (2020). Vascular dimorphism ensured by regulated proteoglycan dynamics favors rapid umbilical artery closure at birth. eLife. 9. 16 indexed citations

2.

Zhao, Shulin, et al.. (2014). Genetic alterations of protein tyrosine phosphatases in human cancers. Oncogene. 34(30). 3885–3894. 59 indexed citations

3.

Hao, Yujun, Chao Wang, Bo Cao, et al.. (2013). Gain of Interaction with IRS1 by p110α-Helical Domain Mutants Is Crucial for Their Oncogenic Functions. Cancer Cell. 23(5). 583–593. 79 indexed citations

4.

Zhang, Peng, Yiqing Zhao, Xiao‐Feng Zhu, et al.. (2011). Cross-talk between Phospho-STAT3 and PLCγ1 Plays a Critical Role in Colorectal Tumorigenesis. Molecular Cancer Research. 9(10). 1418–1428. 29 indexed citations

5.

Du, Zhanwen, Jing Song, Yong Wang, et al.. (2010). DNMT1 Stability Is Regulated by Proteins Coordinating Deubiquitination and Acetylation-Driven Ubiquitination. Science Signaling. 3(146). ra80–ra80. 268 indexed citations

6.

Li, Long Shan, Julio C. Morales, Martina Veigl, et al.. (2009). DNA mismatch repair (MMR)‐dependent 5‐fluorouracil cytotoxicity and the potential for new therapeutic targets. British Journal of Pharmacology. 158(3). 679–692. 60 indexed citations

7.

Takeshita, Iwao, Sandra H. Bigner, Jun‐Yang Liou, et al.. (1981). 112 A THYMIDINE-KINASE (TK) DEFICIENT 5-BROMO 2ʼDEOXYURIDINE (BUDR) RESISTANT HUMAN GLIOMA (HGL)-DERIVED PERMANENT CELL LINE THAT EXPRESSES GLIAL FIBRILLARY ACIDIC PROTEIN (GFAP). Journal of Neuropathology & Experimental Neurology. 40(3). 336–336. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact